Leverage Shares 3x Long Biotechnology ETP Securities XS2399370399
1.90
USD
-0.19
USD
-8.91
%
20.12.2023
NAV
Zu diesem Instrument liegen derzeit keine aktuellen Daten vor.
| Kurse | Charts | Stammdaten | Kennzahlen | Aktion |
|---|---|---|---|---|
| Snapshot | Preischart | Daten + Gebühr | Performance | Portfolio |
| Börsenplätze | Performance | Management | Volatilität | Watchlist |
| Historisch | Benchmark | Sharpe Ratio | ||
| Rendite | Ratings |
Kurse
Charts
Stammdaten
Kennzahlen
Nettoinventarwert (NAV)
| 1.90 USD | -0.19 USD | -8.91 % |
|---|
| Vortag | 2.09 USD | Datum | 20.12.2023 |
Leverage Shares 3x Long Biotechnology ETP Securities Kurs - 1 Jahr
Anzeige
Top Kryptowährungen ETPs
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Bitcoin Cash ETP | CH0475552201 | 29.30% | |
| 21Shares Tezos ETP | CH0491507486 | 4.21% | |
| 21Shares Bitcoin Gold ETP | CH1146882308 | 2.24% | |
| 21Shares Render ETP | CH1396343266 | -7.84% | |
| 21Shares Bitcoin Core ETP | CH1199067674 | -10.15% | |
| 21Shares XDC Network ETP | CH1464217285 | -22.32% | |
| 21Shares Sui Staking ETP | CH1360612159 | -23.32% | |
| 21Shares Dogecoin ETP | CH1431521033 | -25.54% | |
| 21Shares Cronos Staking ETP | CH1443364232 | -28.67% | |
| 21Shares Jupiter ETP | CH1480821383 | -36.22% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Binance BNB ETP | CH0496454155 | 22.40% | |
| 21Shares Bitcoin Gold ETP | CH1146882308 | 15.55% | |
| 21Shares Bitcoin Cash ETP | CH0475552201 | 14.18% | |
| 21Shares Ethereum Core Staking ETP Acc | CH1209763130 | -8.64% | |
| 21Shares Ethereum Staking ETP | CH0454664027 | -9.10% | |
| 21Shares Cronos Staking ETP | CH1443364232 | -17.13% | |
| 21Shares Dogecoin ETP | CH1431521033 | -44.85% | |
| 21Shares XDC Network ETP | CH1464217285 | -48.55% | |
| 21Shares Immutable ETP | CH1360612142 | -51.56% | |
| 21Shares Sui Staking ETP | CH1360612159 | -56.21% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Bitcoin Gold ETP | CH1146882308 | 42.38% | |
| 21Shares Binance BNB ETP | CH0496454155 | 25.51% | |
| 21Shares Bitcoin Cash ETP | CH0475552201 | 21.44% | |
| 21Shares Ethereum Core Staking ETP Acc | CH1209763130 | -3.91% | |
| 21Shares Ethereum Staking ETP | CH0454664027 | -4.82% | |
| 21Shares Sui Staking ETP | CH1360612159 | -63.49% | |
| 21Shares Injective Staking ETP | CH1360612134 | -78.05% | |
| 21Shares Immutable ETP | CH1360612142 | -81.17% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares XRP ETP | CH0454664043 | 244.02% | |
| 21Shares Binance BNB ETP | CH0496454155 | 179.46% | |
| 21Shares Crypto Basket Equal Weight (HODLV) ETP | CH1135202161 | 178.19% | |
| 21Shares Bitcoin Cash ETP | CH0475552201 | 135.88% | |
| 21Shares Bitcoin Gold ETP | CH1146882308 | 127.18% |
Fundamentaldaten
| Valor | |
| ISIN | XS2399370399 |
| Emittent | Leverage Shares PLC |
| Aufgelegt in | Ireland |
| Auflagedatum | 10.12.2021 |
| Kategorie | Trading - Leveraged/Inverse Aktien |
| Währung | USD |
| Volumen | 174’227.98 |
| Depotbank | |
| Geschäftsjahresende | |
| Berichtsstand | 22.12.2023 |
Anlagepolitik
So investiert der Leverage Shares 3x Long Biotechnology ETP Securities: The objective of the ETP Securities is to provide 3 times the value of the daily performance of the
iShares Biotechnology ETF Exchange Traded Fund, net of fees and expenses. The ETP securities
seek to pursue the 3x Long Biotechnology Investment Strategy (the "Investment Strategy") which
provides exposure to 3 times the daily performance of the iShares Biotechnology ETF Exchange
Traded Fund (the “Reference Asset”).
ETP Performance: Leverage Shares 3x Long Biotechnology ETP Securities
| Performance 1 Jahr | -25.66 | |
| Performance 2 Jahre | - | |
| Performance 3 Jahre | - | |
| Performance 5 Jahre | - | |
| Performance 10 Jahre | - |